Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Neil Woodford's full portfolio revealed

Neil Woodford's full portfolio revealed

(Update) Star fund manager Neil Woodford has just under a third of his fund in healthcare stocks, alongside significant weightings in consumer goods companies and financials.

His eponymous fund firm is seeking to fight opacity in the fund industry by disclosing all of the underlying holdings in the CF Woodford Equity Income fund.

The fund has 31.8% in healthcare companies, while consumer goods and financials represent the fund's next two largest sector weightings at 20% and 17% of the portfolio respectively. 

Woodford disclosed his top 10 positions last week, which bore an unsurprising similarity to the top 10 of his former Invesco Perpetual Income fund, with AstraZeneca and GlaxoSmithKline featuring as his top two. 

Allied Minds, which floated last month, BAE Systems, Legal & General, AA and SSE feature among the fund's top 20. 

The 61-stock portfolio includes Prothena, Altria, outsourcing firm G4S and nuclear power firm Drax.

Other stocks that form part of the fund's financials exposure include Provident Financial, Gagfah, Redde, Lancashire, Catlin, Hiscox and Beasley.

Revolymer, the maker of non-stick chewing gum, also features among Woodford’s picks.

Within consumer goods companies, Woodford is backing Philip Morris International, Altria and retailer Next.

Oxford Pharmascience, e-Therapeutics and 4D Pharma also feature in his substantial healthcare allocation.

Here is the full portfolio:

Full Portfolio (30 June 2014)
NAME INDUSTRY % (WEIGHT)
1 AstraZeneca Health Care 8.3
2 GlaxoSmithKline Health Care 7.11
3 British American Tobacco Consumer Goods 6.2
4 BT Telecommunications 6.02
5 Imperial Tobacco Consumer Goods 5.31
6 Roche Health Care 3.9
7 Imperial Innovations Financials 3.6
8 Reynolds American Consumer Goods 3.55
9 Rolls-Royce Industrials 3.47
10 Capita Industrials 3.36
11 Allied Minds Financials 2.93
12 BAe Systems Industrials 2.91
13 HSBC Financials 2.79
14 Sanofi Health Care 2.34
15 Legal & General Financials 2.09
16 Novartis Health Care 2.01
17 Centrica Utilities 1.98
18 AA Consumer Services 1.87
19 SSE Utilities 1.85
20 Reckitt Benckiser Consumer Goods 1.83
21 Philip Morris International Consumer Goods 1.81
22 Prothena Health Care 1.72
23 Next Consumer Services 1.68
24 Altria Consumer Goods 1.3
25 Smith & Nephew Health Care 1.27
26 BTG Health Care 1.22
27 Provident Financial Financials 1.13
28 Drax Utilities 1.11
29 Alkermes Health Care 1.04
30 Gagfah Financials 1.02
31 G4S Industrials 0.97
32 RM2 International Industrials 0.93
33 Redde Financials 0.9
34 Utilitywise Industrials 0.62
35 Serco Industrials 0.59
36 Meggitt Industrials 0.59
37 Lancashire Financials 0.58
38 Velocys Oil & Gas 0.55
39 e-Therapeutics Health Care 0.54
40 Vernalis Health Care 0.49
41 ReNeuron Health Care 0.48
42 Cobham Industrials 0.48
43 Burford Capital Financials 0.44
44 Catlin Financials 0.43
45 Benchmark Health Care 0.43
46 Amlin Financials 0.43
47 4D Pharma Health Care 0.43
48 Oxford Pharmascience Health Care 0.35
49 Revolymer Basic Materials 0.31
50 Hiscox Financials 0.31
51 Beazley Financials 0.29
52 Gigaclear Telecommunications 0.29
53 Paypoint Industrials 0.25
54 Homeserve Industrials 0.09
55 Retroscreen Virology Health Care 0.09
56 Xeros Industrials 0.07
57 NetScientific Health Care 0.05
58 IP Financials 0.04
59 Circassia Health Care 0.03
60 Stobart Industrials 0.03
61 Cranswick Consumer Goods 0.01

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Kames' Ennett: Trump good for US high yield, but beware Europe

Kames' Ennett: Trump good for US high yield, but beware Europe

Kames Capital’s head of high yield David Ennett believes the changing political landscape will be a positive for the US, but negative for Europe in 2017.

Play Philip Milburn: why inflation won't run out of control

Philip Milburn: why inflation won't run out of control

Kames bond fund manager views inflation as more of 'scare' than a 'problem' and is positioning his portfolios accordingly.

Play Henderson's Lofthouse on merger boost and political risk

Henderson's Lofthouse on merger boost and political risk

Ben Lofthouse talks through where he is finding income and what surprises await the global economy in the new year.

Read More
Your Business: Cover Star Club

Profile: why Patronus Partners' founder left the only job he ever knew

Profile: why Patronus Partners' founder left the only job he ever knew

'There was a definite idea of how things would work out over 12 months. When we look back, that was inaccurate'

Wealth Manager on Twitter